Research programme: taxane derivatives - IndenaAlternative Names: IDN 5390; IDN 6140
Latest Information Update: 17 Nov 2008
At a glance
- Originator Indena
- Class Paclitaxels; Taxanes
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 24 Oct 2008 Pharmacodynamics data from a preclinical trial in glioma presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR-2008)
- 06 Nov 2007 Preclinical trials in Cancer in Italy (IV)
- 06 Nov 2007 Clinical data presented at the 19th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (AACR-NCI-EORTC-2007) added to the pharmacokinetics section